Figure 8
From: ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19
Per residual decomposition energy of selected compounds (Daunorubicin in red, Onalespib in blue, ABBV-744 in green and αk-13b inhibitor in magenta) bound to Mpro enzyme calculated with MMGB/SA approach.
